BPA for valchlor
Ended Awarded Last action
- Contract number
- 36E79724A0004
- Awardee
-
Helsinn Therapeutics (U.s.), Inc. UEI H7RDUVXHP8L3
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $15,475,951.95
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center has awarded a Blanket Purchase Agreement (BPA) to Helsinn Therapeutics (U.S.), Inc., a for-profit pharmaceutical manufacturer, to provide the drug VALCHLOR. VALCHLOR is used to treat cutaneous T-cell lymphoma. The BPA has a ceiling value of $15,475,951.95 and a period of performance through February 2025. This BPA allows VA medical facilities to efficiently procure VALCHLOR on an as-needed basis to treat veterans with this condition. The contract was a single award, with no set-aside provisions applied. Performance will be carried out within the United States by Helsinn Therapeutics as the prime contractor.
In addition to this BPA, Helsinn Therapeutics has received several recent delivery orders from the VA to provide VALCHLOR gel. These orders were placed against the Pharmaceuticals and Drugs GSA Schedule, had potential values of $36,471.15 each, and had completion dates ranging from February 2019 to November 2019. The BPA and delivery orders facilitate the VA's ability to efficiently procure and distribute VALCHLOR to treat veterans with cutaneous T-cell lymphoma.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79724A0004?
36E79724A0004 was awarded to Helsinn Therapeutics (U.s.), Inc. by National Acquisition Center (Headquarters) on November 14, 2023.
How much is contract 36E79724A0004 worth?
36E79724A0004's own ceiling is $15,475,952.
Who can order from contract 36E79724A0004?
36E79724A0004 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79724A0004 under another contract?
Yes. 36E79724A0004 is a blanket purchase agreement under V797D70240, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79724A0004 competed?
The extent of competition for 36E79724A0004 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV